Market Cap 20.61B
Revenue (ttm) 4.37B
Net Income (ttm) -1.22B
EPS (ttm) N/A
PE Ratio 31.29
Forward PE 28.98
Profit Margin -27.97%
Debt to Equity Ratio 0.42
Volume 1,700,200
Avg Vol 1,774,590
Day's Range N/A - N/A
Shares Out 152.80M
Stochastic %K 83%
Beta 1.44
Analysts Sell
Price Target $117.47

Company Profile

Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa. The company offers sequencing- and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other g...

Industry: Diagnostics & Research
Sector: Healthcare
Phone: 858 202 4500
Fax: 858 202 4545
Address:
5200 Illumina Way, San Diego, United States
kevin_davis07f
kevin_davis07f Dec. 12 at 5:50 PM
$ILMN Mainz Biomed is my favorite kind of setup because $1.00 holds, VWAP is right there at ~1.027, and the catalyst stack has real scale like ~4,000,000 UK invites yearly plus DoctorBox 10,000,000+ results handled
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 11 at 11:14 PM
Actionable Trade Alert for $ILMN Market Context: $ILMN is currently trading at $135.59, showing strong momentum but with an RSI of 79.64, indicating overbought conditions. The stock is near its 60D high of $136.64, suggesting potential resistance at this level. Directional Bias: The high RSI and proximity to the 60D high indicate a bearish reversal may be imminent. However, the MA30 (124.17) and MA50 (113.43) show bullish trends, providing support if the price retraces. Trade Plan: - Suggested Entry: $135.00 (slightly below current price for a better entry) - Stop Loss: $130.00 (below recent support) - Take Profit Targets: - TP1: $140.00 (3.6% gain) - TP2: $145.00 (6.9% gain) - TP3: $159.00 (17.4% gain) This plan allows for a strategic entry while managing risk effectively. Monitor the price action closely for any signs of reversal or continuation. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
tylerhughes05
tylerhughes05 Dec. 11 at 7:40 PM
$ILMN Mainz Biomed hasn’t seen real volume in days, but that’s the point — when a forgotten chart like this finally hits scanners on a +15% move, it’s already too late to think 🧠🔥
0 · Reply
Thestocktraderhubzee
Thestocktraderhubzee Dec. 11 at 2:26 PM
$ILMN Illumina Invests In MyOme, Announcing Collaboration To Advance Proactive Health Trial Using WGS With AI Risk Models For Chronic, Rare Diseases And Cancer
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 10 at 3:17 AM
Actionable Trade Alert for $ILMN: Market Context: $ILMN is currently trading at $132.13, showing strength but nearing overbought conditions with an RSI of 68.96. The stock has recently approached its 60D high of $134.79, indicating potential resistance. Directional Bias: The bullish sentiment is supported by the price being above the 30-day (MA30) and 50-day (MA50) moving averages, which are at $121.58 and $111.97, respectively. However, the RSI suggests caution as it approaches overbought territory. Trade Plan: - Suggested Entry: $132.50 - Stop Loss: $128.00 (risking $4.50) - Take Profit Targets: 1. $136.00 (Target 1, +$3.50, 2.64% ROI) 2. $140.00 (Target 2, +$7.50, 5.67% ROI) 3. $155.00 (Target 3, +$22.87, 17.29% ROI) With the potential for a significant upside, consider entering at $132.50, placing a stop at $128.00, and targeting $136.00, $140.00, and $155.00. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
mstan
mstan Dec. 9 at 6:47 PM
$ILMN wtf😁
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 8 at 11:05 PM
Actionable Trade Alert for $ILMN: Market Context: $ILMN is currently trading at $127.54, showing bullish momentum with an RSI of 65.84, indicating potential overbought conditions but still room for upward movement. The price is above the 30-day moving average (MA30) of 120.53 and significantly above the 50-day moving average (MA50) of 111.17, suggesting a strong bullish trend. The 60-day high of 132.15 provides a key resistance level. Directional Bias: Bullish. The price action above key moving averages and the proximity to the 60D high supports a positive outlook. Trade Plan: - Suggested Entry: $128.00 - Stop Loss: $123.73 (1 ATR below entry) - Take Profit Targets: 1. $132.15 (60D High) 2. $135.00 3. $149.00 (17% ROI) Monitor the trade closely as it approaches the targets. Adjust stop loss to protect profits as necessary. https://privateprofiteers.com
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 6 at 2:05 AM
Actionable Trade Alert for $ILMN: Market Context: $ILMN is currently trading at $128.03, showing strong bullish momentum with an RSI of 68.0, indicating it's nearing overbought territory. However, the price remains above the 30-day moving average (MA30) of 118.65 and the 50-day moving average (MA50) of 109.71, suggesting a bullish trend. Directional Bias: The recent high of $132.15 indicates potential resistance, while the low of $88.00 provides a solid support base. The strong upward movement suggests a continuation of the bullish trend, but caution is advised due to the high RSI. Trade Plan: - Suggested Entry: $128.03 - Stop Loss: $124.00 (approx. 3% below entry) - Take Profit Targets: 1. Target 1: $132.00 (3% gain) 2. Target 2: $136.00 (6% gain) 3. Target 3: $150.00 (17% gain) With this plan, we aim for a minimum of 17% ROI on the third target while managing risk effectively. https://privateprofiteers.com
0 · Reply
BillionerOfKing
BillionerOfKing Dec. 3 at 9:45 AM
$ILMN Current Stock Price: $127.57 Contracts to trade: $130 ILMN Dec 19 2025 Call Entry: $3.38 Exit: $5.17 ROI: 53% Hold ~20 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
Drew5896
Drew5896 Dec. 1 at 3:55 PM
$ILMN got some Jan $150 in case it wants another leg
0 · Reply
Latest News on ILMN
Illumina To Webcast Upcoming Investor Conference

Nov 11, 2025, 4:05 PM EST - 4 weeks ago

Illumina To Webcast Upcoming Investor Conference


Illumina, Inc. (ILMN) Q3 2025 Earnings Call Transcript

Oct 30, 2025, 10:26 PM EDT - 6 weeks ago

Illumina, Inc. (ILMN) Q3 2025 Earnings Call Transcript


ILMN Stock vs. IQV Stock

Sep 26, 2025, 9:40 AM EDT - 2 months ago

ILMN Stock vs. IQV Stock

IQV


mRNA Biotechs - Long-Term Value Risks Abound

Aug 28, 2025, 6:20 AM EDT - 3 months ago

mRNA Biotechs - Long-Term Value Risks Abound

ALNY BNTX DHR GRAL IONS MRNA RGEN


Illumina: The Stock Is Still Undervalued

Aug 4, 2025, 4:23 AM EDT - 4 months ago

Illumina: The Stock Is Still Undervalued


Illumina (ILMN) Q2 EPS Jumps 9%

Aug 1, 2025, 7:23 PM EDT - 4 months ago

Illumina (ILMN) Q2 EPS Jumps 9%


Illumina, Inc. (ILMN) Q2 2025 Earnings Call Transcript

Aug 1, 2025, 1:25 AM EDT - 4 months ago

Illumina, Inc. (ILMN) Q2 2025 Earnings Call Transcript


Illumina: A 5.2 Rating Amid Challenges and Opportunities

Jul 31, 2025, 7:00 PM EDT - 4 months ago

Illumina: A 5.2 Rating Amid Challenges and Opportunities


Illumina Stock: What Went Wrong And Why It's Best To Stay Away

Jul 17, 2025, 7:45 AM EDT - 5 months ago

Illumina Stock: What Went Wrong And Why It's Best To Stay Away


Illumina Analysts Lower Their Forecasts After Q1 Results

May 12, 2025, 11:28 AM EDT - 7 months ago

Illumina Analysts Lower Their Forecasts After Q1 Results


Illumina: Multiple Headwinds Point To Limited Upside In 2025

May 10, 2025, 10:58 PM EDT - 7 months ago

Illumina: Multiple Headwinds Point To Limited Upside In 2025


Illumina, Inc. (ILMN) Q1 2025 Earnings Call Transcript

May 8, 2025, 9:01 PM EDT - 7 months ago

Illumina, Inc. (ILMN) Q1 2025 Earnings Call Transcript


kevin_davis07f
kevin_davis07f Dec. 12 at 5:50 PM
$ILMN Mainz Biomed is my favorite kind of setup because $1.00 holds, VWAP is right there at ~1.027, and the catalyst stack has real scale like ~4,000,000 UK invites yearly plus DoctorBox 10,000,000+ results handled
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 11 at 11:14 PM
Actionable Trade Alert for $ILMN Market Context: $ILMN is currently trading at $135.59, showing strong momentum but with an RSI of 79.64, indicating overbought conditions. The stock is near its 60D high of $136.64, suggesting potential resistance at this level. Directional Bias: The high RSI and proximity to the 60D high indicate a bearish reversal may be imminent. However, the MA30 (124.17) and MA50 (113.43) show bullish trends, providing support if the price retraces. Trade Plan: - Suggested Entry: $135.00 (slightly below current price for a better entry) - Stop Loss: $130.00 (below recent support) - Take Profit Targets: - TP1: $140.00 (3.6% gain) - TP2: $145.00 (6.9% gain) - TP3: $159.00 (17.4% gain) This plan allows for a strategic entry while managing risk effectively. Monitor the price action closely for any signs of reversal or continuation. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
tylerhughes05
tylerhughes05 Dec. 11 at 7:40 PM
$ILMN Mainz Biomed hasn’t seen real volume in days, but that’s the point — when a forgotten chart like this finally hits scanners on a +15% move, it’s already too late to think 🧠🔥
0 · Reply
Thestocktraderhubzee
Thestocktraderhubzee Dec. 11 at 2:26 PM
$ILMN Illumina Invests In MyOme, Announcing Collaboration To Advance Proactive Health Trial Using WGS With AI Risk Models For Chronic, Rare Diseases And Cancer
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 10 at 3:17 AM
Actionable Trade Alert for $ILMN: Market Context: $ILMN is currently trading at $132.13, showing strength but nearing overbought conditions with an RSI of 68.96. The stock has recently approached its 60D high of $134.79, indicating potential resistance. Directional Bias: The bullish sentiment is supported by the price being above the 30-day (MA30) and 50-day (MA50) moving averages, which are at $121.58 and $111.97, respectively. However, the RSI suggests caution as it approaches overbought territory. Trade Plan: - Suggested Entry: $132.50 - Stop Loss: $128.00 (risking $4.50) - Take Profit Targets: 1. $136.00 (Target 1, +$3.50, 2.64% ROI) 2. $140.00 (Target 2, +$7.50, 5.67% ROI) 3. $155.00 (Target 3, +$22.87, 17.29% ROI) With the potential for a significant upside, consider entering at $132.50, placing a stop at $128.00, and targeting $136.00, $140.00, and $155.00. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
mstan
mstan Dec. 9 at 6:47 PM
$ILMN wtf😁
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 8 at 11:05 PM
Actionable Trade Alert for $ILMN: Market Context: $ILMN is currently trading at $127.54, showing bullish momentum with an RSI of 65.84, indicating potential overbought conditions but still room for upward movement. The price is above the 30-day moving average (MA30) of 120.53 and significantly above the 50-day moving average (MA50) of 111.17, suggesting a strong bullish trend. The 60-day high of 132.15 provides a key resistance level. Directional Bias: Bullish. The price action above key moving averages and the proximity to the 60D high supports a positive outlook. Trade Plan: - Suggested Entry: $128.00 - Stop Loss: $123.73 (1 ATR below entry) - Take Profit Targets: 1. $132.15 (60D High) 2. $135.00 3. $149.00 (17% ROI) Monitor the trade closely as it approaches the targets. Adjust stop loss to protect profits as necessary. https://privateprofiteers.com
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 6 at 2:05 AM
Actionable Trade Alert for $ILMN: Market Context: $ILMN is currently trading at $128.03, showing strong bullish momentum with an RSI of 68.0, indicating it's nearing overbought territory. However, the price remains above the 30-day moving average (MA30) of 118.65 and the 50-day moving average (MA50) of 109.71, suggesting a bullish trend. Directional Bias: The recent high of $132.15 indicates potential resistance, while the low of $88.00 provides a solid support base. The strong upward movement suggests a continuation of the bullish trend, but caution is advised due to the high RSI. Trade Plan: - Suggested Entry: $128.03 - Stop Loss: $124.00 (approx. 3% below entry) - Take Profit Targets: 1. Target 1: $132.00 (3% gain) 2. Target 2: $136.00 (6% gain) 3. Target 3: $150.00 (17% gain) With this plan, we aim for a minimum of 17% ROI on the third target while managing risk effectively. https://privateprofiteers.com
0 · Reply
BillionerOfKing
BillionerOfKing Dec. 3 at 9:45 AM
$ILMN Current Stock Price: $127.57 Contracts to trade: $130 ILMN Dec 19 2025 Call Entry: $3.38 Exit: $5.17 ROI: 53% Hold ~20 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
Drew5896
Drew5896 Dec. 1 at 3:55 PM
$ILMN got some Jan $150 in case it wants another leg
0 · Reply
labibaouf
labibaouf Nov. 25 at 7:43 PM
$ILMN used to be $500 wtf
1 · Reply
Farorm
Farorm Nov. 25 at 7:37 PM
$ILMN worst “advise”. Clear change of character, I’m hella long.
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Nov. 25 at 2:30 PM
$ILMN RSI: 58.08, MACD: 5.4133 Vol: 7.89, MA20: 119.18, MA50: 106.20 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
Drew5896
Drew5896 Nov. 24 at 7:37 PM
$ILMN like the look of breaking over highs. Got some Dec $120 and $135
0 · Reply
BEATOFtheMARKET
BEATOFtheMARKET Nov. 22 at 9:09 PM
0 · Reply
SweepCastApp
SweepCastApp Nov. 22 at 8:26 PM
$ILMN: Unusual Options Activity Alerted CALL flow observed 121x contracts at Strike price of $130 Exp on 12/19/2025 with Premium of $35K and showing BEARISH Sentiment
0 · Reply
TimisoaraTitans
TimisoaraTitans Nov. 21 at 8:24 AM
📉 The Simple $WGS Bear Case (by courtesy of AI) $WGS lives in a tiny niche. If $ILMN, $TMO or $A ever focused on clinical genomes, they could pressure pricing fast. The business model isn’t proven: whole-genome tests are expensive to run, slow to get reimbursed, and require lots of manual work. TAM (Total Addressable Market) is likely smaller than bulls claim because most families never get approved for full-genome testing. Revenue also depends on a few big customers, so losing one hurts. Cash burn today means possible dilution later. Their “moat” is shrinking as genome interpretation gets cheaper and easier for all labs. Their dataset isn’t unique enough to be a Google-style monopoly. And adoption is slow — each patient requires doctors, insurance, and clinical review. They talk like SaaS (Software as a Service), but it’s really a medical lab. Genomics history is full of great science but terrible investor returns.
1 · Reply
marlowe_rojas
marlowe_rojas Nov. 20 at 9:32 PM
$ILMN about to wake up. Don’t sleep!!
0 · Reply
Albino_Trader123
Albino_Trader123 Nov. 20 at 3:24 PM
$ILMN Nice breakout
0 · Reply
appayip
appayip Nov. 17 at 2:52 PM
$ILMN will speak at Wolfe Research Healthcare Conference on November 19. in case price moves and you wonder why.
0 · Reply
BEATOFtheMARKET
BEATOFtheMARKET Nov. 17 at 12:48 AM
0 · Reply
Sunnytrading90
Sunnytrading90 Nov. 14 at 10:37 PM
$ILMN long
0 · Reply